Veracyte

Veracyte

Yahoo Finance • yesterday

Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku

Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story

Yahoo Finance • 2 days ago

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader, market-cap-weighted industry exposure. Both... Full story

Yahoo Finance • 7 days ago

Texas Stock Exchange live in Dallas. Y'all Street takes on Wall Street

Move over, New York and Nasdaq — there's a new stock exchange in Texas. On Monday, the Texas Stock Exchange (TXSE) in Dallas went live — but only for members — as it began test trading of designated securities with live trading set to sta... Full story

Yahoo Finance • 10 days ago

A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.

Jonathan Wygant, Vice President and Chief Accounting Officer of Veracyte (NASDAQ:VCYT), reported the exercise of 24,000 options and immediate open-market sale of the same number of shares for a total transaction value of approximately $1.0... Full story

Yahoo Finance • 17 days ago

What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally

Karin Eastham, a director of Veracyte (NASDAQ:VCYT), reported the sale of 3,729 shares of common stock in multiple open-market transactions on June 18, 2026, as detailed in the SEC Form 4 filing. Transaction summary Metric Value Shares s... Full story

Yahoo Finance • 27 days ago

Dow Jones Futures: Techs Rebound, SpaceX Rises Despite Trump's Iran Threat; Warsh's Fed Debut Due

The Dow Jones hit a new high and SpaceX kept rising. But chips and most AI stocks fell. Fed chief Kevin Warsh's comments will be in focus Wednesday. Continue Reading... Full story

Yahoo Finance • 27 days ago

Dow Jones Futures Rise Before Warsh's Fed Debut; SpaceX Keeps Rising, Four Stocks In Buy Areas

The Dow Jones hit a new high and SpaceX kept rising. But chips and most AI stocks fell. Fed chief Kevin Warsh's comments will be in focus Wednesday. Continue Reading... Full story

Yahoo Finance • 28 days ago

Dow Jones Hits High, SpaceX Keeps Rising, But AI Stocks Skid; Warsh's Fed Debut On Tap

The Dow Jones hit a new high and SpaceX kept rising. But chips and most AI stocks fell. Fed chief Kevin Warsh's comments will be in focus Wednesday. Continue Reading... Full story

Yahoo Finance • last month

State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?

The State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund(NYSEMKT:FBT) provides concentrated exposure to biotechnology.... Full story

Yahoo Finance • 2 months ago

Why Veracyte Stock Is Skyrocketing Higher This Week

Key Points Veracyte grew revenue by 21% in Q1 and saw earnings per share quadruple from last year, as margins ballooned. Sales for the company's main prostate and thyroid cancer-detecting tests continue to grow by double-digit rates. On t... Full story

Yahoo Finance • 2 months ago

A Look At Veracyte (VCYT) Valuation As New Decipher Bladder And Prostate Data Heads To AUA 2026

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Veracyte (VCYT) is back in focus after announcing that more than 15 Decipher Bladder and Prostate... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure

Joe Raedle Cathie Wood’s ARK Invest funds executed a broad rotation across technology, healthcare, and industrial names during the last week while markets remained volatile over broader geopolitical tensions between the U.S. and Iran. Bu... Full story

Yahoo Finance • 3 months ago

Cathie Wood Just Snapped Up This Nvidia Cloud Play — Here's Everything Else Ark Traded Monday

On Monday, Ark Invest, led by Cathie Wood, made significant trades, notably acquiring shares of CoreWeave Inc. This purchase aligns with Ark’s strategy of investing in innovative technology companies. CoreWeave, a cloud platform built on N... Full story

Yahoo Finance • 5 months ago

What Veracyte (VCYT)'s UBS Rating Reaffirmation and 2026 Outlook Means For Shareholders

UBS recently reaffirmed its Buy rating on Veracyte after the company’s fourth-quarter testing revenue came in ahead of expectations and management issued 2026 testing revenue projections that were higher than consensus estimates. The analy... Full story

Yahoo Finance • 5 months ago

UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue

Veracyte, Inc. (NASDAQ:VCYT) ranks among the best innovative stocks to buy according to Wall Street analysts. On January 12, UBS reaffirmed its Buy rating for Veracyte, Inc. (NASDAQ:VCYT) alongside a price target of $48. Analyst Lu Li reta... Full story

Yahoo Finance • 5 months ago

BD Merges Biosciences & Diagnostics Business With Waters

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of the separated entity with Waters Corpo... Full story

Yahoo Finance • 6 months ago

Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT)

Veracyte, Inc. (NASDAQ:VCYT) is among the 12 Best Genomics Stocks to Invest In.Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) The Fly reported on December 2, 2025, that Morgan Stanley began covering Veracyte, Inc. (NASDAQ:VCYT... Full story

Yahoo Finance • 6 months ago

Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., December 29, 2025--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thur... Full story

Yahoo Finance • 6 months ago

3 Medical Instrument Stocks to Counter Industry Woes Using GenAI

Over the past year, the application of generative AI (genAI) in the Medical Instruments industry has moved from experimental to operational, transforming diagnostics, patient monitoring and intervention workflows. Insights from a U.S. Nati... Full story

Yahoo Finance • 8 months ago

Veracyte (VCYT) Turns Profitable, But Significant $27M Loss Challenges Bullish Narratives

Veracyte (VCYT) recently moved into profitability, with its net profit margin turning positive even as a significant, non-recurring loss of $27.0 million affected the latest twelve-month results to September 30, 2025. Over the past five ye... Full story